• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE ELECSYS PTH TEST SYSTEM; PARATHYROID HORMONE TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE ELECSYS PTH TEST SYSTEM; PARATHYROID HORMONE TEST SYSTEM Back to Search Results
Catalog Number 08928410190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/24/2024
Event Type  malfunction  
Manufacturer Narrative
The e602 module serial number was (b)(6).The competitor method was liaison xl.The sample was requested for investigation.
 
Event Description
The initial reporter complained of high results not corresponding to the clinical status for 1 patient sample tested for elecsys pth stat (pth stat) on a cobas 8000 e 602 module.The following results were from the e602 module: the initial result was 413 ng/l.The result using ½ dilution was 292.7 ng/l.The result using ¼ dilution was 170 ng/l.The result with veraprep treatment was 470 ng/l.The result with polyethylene glycol (peg) treatment was 11 ng/l.The result from a competitor method was 345 ng/l.The customer suspects an interference.
 
Manufacturer Narrative
The sample was received for investigation.The sample was tested on an e602 module with pth stat reagent lot 722334 and pth 1-84 reagent lot 733232.The sample was tested untreated and after heterophilic blocking tube (hbt) treatment.Pth 1-84: 200.3 pg/ml (untreated), 203.2 pg/ml (after hbt treatment) pth stat: 385.6 pg/ml (untreated), 390.3 pg/ml (after hbt treatment) the investigation confirmed the customer's high pth stat results.The sample was investigated further by size exclusion chromatography (sec).The investigation results suggest the presence of igg antibodies leading to the formation of a macromolecule igg - pth which was detected by the elecsys pth stat assay and the competitor assay.Product labeling states: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE ELECSYS PTH TEST SYSTEM
Type of Device
PARATHYROID HORMONE TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18672408
MDR Text Key334952550
Report Number1823260-2024-00380
Device Sequence Number1
Product Code CEW
Combination Product (y/n)Y
Reporter Country CodeBE
PMA/PMN Number
K070709
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/08/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08928410190
Device Lot Number72233401
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-